VAERS Explorer
Back to explore

Report #2827712

Received Feb 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
0.3 yrs
State
GA
Recovered
Unknown
Vaccinated
Feb 11, 2025
Onset
Feb 11, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEURUNKU8518AAOT / RL

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

4-month-old patient got the FLUZONENP shot by accident, with no reported adverse event; Initial information received on 12-Feb-2025 regarding an unsolicited valid non-serious case received from a physician. This case involves a 4-month-old patient got the Influenza USP trival A-B subvirion no preservative vaccine (Fluzonenp) shot by accident, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Rotavirus vaccine: and diphtheria, tetanus, AC pertussis, IPV and HIB vaccine (Pentacel). On 11-Feb-2025, the 4-month-old patient received a 0.5 ml dose of suspect Influenza USP trival A-B subvirion no preservative vaccine Suspension for injection, strength-standard (lot U8518AA) (expiry date- 30-Jun-2025) via intramuscular route in Right Vastus Lateralis for influenza immunization (Influenza immunisation) and shot by accident, with no adverse event reported (product administered to patient of inappropriate age) (latency: same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Other medications

ROTAVIRUS VACCINE; PENTACEL